Skolyn
Baku
About Skolyn
Skolyn is a clinical-stage computational imaging and artificial intelligence company architecting the foundational technologies for the next era of diagnostic medicine. The company's core mission is to resolve the systemic inefficiencies confronting modern radiology, including unsustainable workloads, high clinician burnout rates, and persistent diagnostic error rates. Skolyn's key technological differentiator is its "Clarity Engine," a suite of deep learning models trained on vast datasets of raw k-space data (from initiatives like the fastMRI+ project), which enables the reconstruction of medical images from undersampled data. This technology can significantly reduce MRI scan times while simultaneously improving image quality. Built upon this foundation, the Skolyn Diagnostic Suite provides clinicians with a universal, multi-modal analysis platform with an initial focus on Musculoskeletal (Knee), Neurology (Brain), and Oncology (Prostate, Breast) MRI. Every module is built upon the inviolable principle of Explainable AI (XAI), providing a complete dossier of evidence for each finding to foster warranted clinical trust. The company operates on a tiered, B2B Software-as-a-Service (SaaS) model, providing annual licenses to hospitals and clinical centers. Skolyn is strategically aligned with national digital health initiatives and is positioned to become a leader in the rapidly growing field of AI-augmented, high-performance medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $10.0K
- Funding stage: Seed
- Last round: Angel (Jul 2025)
- Website: skolyn.se
- Phone: +994515396228
Social Profiles
Canonical: https://fsome.com/organization/skolyn-119934 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.